Cauda Equina Syndrome
Conditions
Keywords
Peristeen Bowel Irrigation System, Cauda Equina Syndrome, Lower Motor Neuron Neurogenic Bowel
Brief summary
To compare the Peristeen Anal Irrigation System with conservative bowel management in a prospective study among spinal cord injured patients with lower motor neuron neurogenic bowel dysfunction.
Detailed description
People with spinal cord injury (SCI) often have severe problems with management of bowel function, including incontinence, impaction, lengthy bowel routines and extremely slow transit times.The anal irrigation system is a recently available system to help patients with bowel dysfunction empty their bowels by using pulse water irrigation. The system consists of a rectal balloon catheter, manual pump and water container.
Interventions
DEVICEPeristeen Bowel Irrigation System
A complete system for bowel Irrigation to manage bowel dysfunction
Sponsors
Manitoba Spinal Cord Injury Research Committee
Canadian Paraplegic Association
University of Manitoba
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female \>18 years or older * Cauda equina spinal injury at least 12 months previously, with lower motor neuron bowel dysfunction and at least one of the following symptoms: * Spending 30 minutes or more attempting to defecate each day or every second day * Episodes of fecal incontinence once or more per month * Abdominal discomfort before or during defecation
Exclusion criteria
* Coexisting major unresolved physical problems due to the injury * Performance of transanal irrigation on a regular basis * Evidence of bowel obstruction or active inflammatory bowel disease * History of cerebral palsy, stroke, multiple sclerosis or diabetic polyneuropathy * Previous colorectal or perineal surgery(excluding minor surgery such as hemorrhoidectomy) * Pregnancy or lactation * Immunosuppression * Prior implant for sacral nerve stimulation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline on Cleveland Clinic Constipation Scoring System after 10 weeks of treatment | At baseline Visit and again after 10 weeks of treatment | A scoring system with a range of 0-30, with 30 representing the most severe symptoms. Will be used for volunteers whose primary complaint at baseline is constipation. |
| Change from baseline on the St. Mark's Fecal Incontinence Grading System after 10 weeks of treatment. | At baseline and again after 10 weeks of treatment | A Grading system with a range of 0-24, with 24 representing the most severe symptoms. This will be used for volunteers whose primary complaint at baseline is fecal incontinence. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline measurement of Colonic Transit Time (CTT)after 10 weeks of treatment | At baseline and again after 10 weeks of treatment. | The Metcalf method will be used.At the screening visit,eligible volunteers will be given a 7-day bowel diary and 3 SitzMark capsules with instructions on how to complete the diary and when to take the capsules. Abdominal X-rays will be obtained on Day 4 and 7. The patient will repeat the diary, SitzMark capsules and X-rays during the last week of study treatment. |
| Change from baseline in The Neurogenic Bowel Dysfunction Score after 10 weeks of treatment | At baseline and again after 10 weeks of treatment | A symptom score ranging from 0-47, where each symptom of neurogenic bowel is weighted concerning it's impact on quality of life. A score of 47 represents severe symptoms. |
| Measurement of Influence of Current Bowel Management on Quality of Life | After 10 weeks of treatment | A numeric box scale with a range of 0-10, with 0 representing great reduction and 10 representing great improvement. |
| Change from baseline on a numeric box scale to measure bowel function, influence on daily activities, and general satisfaction after 10 weeks of treatment. | At baseline and after 10 weeks of treatment. | Numeric box scales with a range of 1-10 |
| Change from baseline in a modified American Society of Colon and Rectal Surgeons fecal incontinence score after 10 weeks of treatment. | At baseline and again after 10 weeks of treatment | Symptom-related Quality of Life Score |
Countries
Canada
Outcome results
None listed